Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities
A Hassanzadeh, HS Rahman, A Markov… - Stem cell research & …, 2021 - Springer
Recently, mesenchymal stem/stromal cells (MSCs) and their widespread biomedical
applications have attracted great consideration from the scientific community around the …
applications have attracted great consideration from the scientific community around the …
Cell-based drug delivery systems and their in vivo fate
L Yang, Y Yang, Y Chen, Y Xu, J Peng - Advanced Drug Delivery Reviews, 2022 - Elsevier
Cell-based drug delivery systems (DDSs) have received attention recently because of their
unique biological properties and self-powered functions, such as excellent biocompatibility …
unique biological properties and self-powered functions, such as excellent biocompatibility …
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches
R Diehl, F Ferrara, C Müller, AY Dreyer… - Cellular & Molecular …, 2017 - nature.com
Almost every experimental treatment strategy using non-autologous cell, tissue or organ
transplantation is tested in small and large animal models before clinical translation …
transplantation is tested in small and large animal models before clinical translation …
Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway
D Lei, L Chengcheng, Q Xuan, C Yibing, W Lei… - Pharmacological …, 2019 - Elsevier
Diabetic nephropathy (DN) is one of the most common microvascular complications of
diabetes and the leading cause of end-stage renal disease. The proliferation of glomerular …
diabetes and the leading cause of end-stage renal disease. The proliferation of glomerular …
Towards a functional cure for diabetes using stem cell-derived beta cells: are we there yet?
S Bourgeois, T Sawatani, A Van Mulders, N De Leu… - Cells, 2021 - mdpi.com
Diabetes mellitus is a pandemic metabolic disorder that results from either the autoimmune
destruction or the dysfunction of insulin-producing pancreatic beta cells. A promising cure is …
destruction or the dysfunction of insulin-producing pancreatic beta cells. A promising cure is …
Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects
GP Fadini, M Albiero, BM Bonora… - The Journal of Clinical …, 2019 - academic.oup.com
Context Diabetes causes severe pathological changes to the microvasculature in many
organs and tissues and is at the same time associated with an increased risk of coronary …
organs and tissues and is at the same time associated with an increased risk of coronary …
Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation
A Miki, C Ricordi, Y Sakuma, T Yamamoto, R Misawa… - PLoS …, 2018 - journals.plos.org
Background Type 1 and Type 2 diabetes mellitus (T1DM and T2DM) are caused by beta (β)-
cell loss and functional impairment. Identification of mechanisms of β-cell death and …
cell loss and functional impairment. Identification of mechanisms of β-cell death and …
Polymeric approaches to reduce tissue responses against devices applied for islet-cell encapsulation
Immunoisolation of pancreatic islets is a technology in which islets are encapsulated in
semipermeable but immunoprotective polymeric membranes. The technology allows for …
semipermeable but immunoprotective polymeric membranes. The technology allows for …
Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications
B Abbasi, K Shamsasenjan, M Ahmadi… - Stem cell research & …, 2022 - Springer
Natural killer cells (NK cells) are innate immune cells that are activated to fight tumor cells
and virus-infected cells. NK cells also play an important role in the graft versus leukemia …
and virus-infected cells. NK cells also play an important role in the graft versus leukemia …
[PDF][PDF] RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
E Razeghian, R Margiana, S Chupradit… - Frontiers in …, 2021 - frontiersin.org
Pro-inflammatory cytokines can effectively be used for tumor immunotherapy, affecting every
step of the tumor immunity cycle. Thereby, they can restore antigen priming, improve the …
step of the tumor immunity cycle. Thereby, they can restore antigen priming, improve the …